Introduction
Malaria is one of the most severe public health problems worldwide though it is entirely preventable and treatable mosquito borne illness. It is a leading cause of death and disease in many developing countries, where young children and pregnant women are the groups most affected. According to the World health Organisation's World Malaria report 2013 and Global Malaria Action plan, 3.4 billion people (half of the world's population) live in areas of malaria transmission in 106 countries and territories [1] . In 2012, malaria caused an estimated 207 million clinical episodes, and 627,000 deaths.
The fight against malaria remains a constant challenge due to rising prevalence of Plasmodium falciparum resistance to chloroquine and many available drugs. New antimalarial agents are urgently needed to counter the spread of drug resistance malaria [2] . The long established use of quinine, artemisinin and its derivatives as highly effective antimalarial demonstrated that plant species are an important resource for the discovery of new antimalarial agents for prophylaxis and treatment. During last decade, several fundamental researches have been conducted to explore anti-malarial activity of many plants [3] .
In traditional medicine whole plant or mixture of plants are used rather than isolated compounds. There are no records attesting the resistance to whole-plant extracts possible due to the synergistic action of their constituents; phytotherapy possible produces fewer adverse effects than chemotherapy [4] .
In the present investigation aerial parts (a combination of different parts of the same plant) Citrus aurantifolia (Christm.) were tested against Plasmodium falciparum 3D7 strain by in vitro method. The plant is commonly known for its therapeutic effectiveness in a variety of diseases in traditional medicine. Furthermore, this plant is among the frequently used medicinal plant with antimalarial properties in Nigeria [5] . .Lime extract has an antimicrobial activity against upper respiratory tract bacterial pathogens [6] . The roots of C. aurantifolia used in traditional medicine for the treatment of fever. A wide range of bioactive ingredient from the citrus species has been found to exert anti-infection and anti-inflammatory activities [7] . The plant has shown antiallergic, anti-inflammatory, anti-cancer, anti-bacterial and anti-protozoal properties [8] . Several anti-oxidant products have also been identified in the seeds of Citrus plant [9] . The present investigation has been undertaken with an objective to establish phytochemicals, cytotoxicity and invitro anti-plasmodial activity of this plant, so that possible plant material could be explored for the treatment of malaria.
II.
Material and Methods
Experimental 1.Plant collection and Identification
Aerial parts of the plant Citrus aurantifolia (Christm.) Swingle commonly known as lime was collected from Mumbai (18º 55´ N, 72º 54´ E) India during May, 2012. The plant was identified by Dr. U. C. Bapat, Head, Department of Botany and Director, Blatter Herbarium, St.Xavier's College, Mumbai. The sample voucher specimen (R2399) of the plant was deposited in the Blatter herbarium.
Extraction of plant material
The Aerial parts of very young plant (secondary branches with tender and young leaves, flower buds, flowers and small unripe fruits) were separated manually and washed twice with distilled water, shade dried, powdered and extracted into 3 extract forms separately which consisted of ethyl acetate, methanol and aqueous using standard extraction procedures [10] . Solvents were removed under reduced pressure by using rotary vacuum evaporator. The per cent yield of extract in each solvent was determined and the crude extracts were stored at 4ºC prior to antimalarial assay. Preliminary phytochemical screening was done using standard procedures [11] .
.Plasmodium falciparum culture and maintenance
The Plasmodium falciparum 3D7 strain was procured from Indian Institute of Technology (IIT), Mumbai, India, was maintained in continuous culture by the modified method of Jensen and Trager [12] in O+ human red blood cells at a 5% haematocrit in RPMI 1640 medium, supplemented with L-glutamine (4.2mM), HEPES (25 mM), NaHCO 3 (25 mM) hypoxanthine (6.8 M), 0.5% AlbumaxII (Invitrogen) and 50μg/ml Gentamicin. Cultures were incubated at 37ºC in an atmosphere of 5% CO 2 , 91% N 2 , and 3% O 2 . Chloroquine was used as positive control.
Invitro antiplasmodial assay
The in vitro activity of crude leaf and stem bark extracts were evaluated against P. falciparum by means of the Mark III test, as developed by the WHO [13] . Briefly, the parasite cultures, prior to experimentation, were synchronized to the ring stage by treatment with 5% D-sorbitol [14] . The two fold serial dilutions of the extracts were prepared in duplicate in 96 well flat bottomed micro plates. Solvent control of 0.5% DMSO and 0.1% methanol to check the effect of solvents on parasite maturation. Filter sterilized extracts (100, 50, 25, 12.5, 6.25 and 3.125 μg/mL) were incorporated in 96 well tissue culture plate containing 200 μL of P. falciparum culture with 2% haematocrit and 1% ring stage infected erythrocytes (parasitemia). The plates were incubated at 37ºC in CO 2 incubator for 40-48h. Parasitemia was evaluated after48 hrs by light microscopy using Giemsa-stained smears as described by Le Bras and Deloron [15] .
The antiplasmodial activities of extracts were expressed by IC 50 , the inhibitory concentrations of the drug that induced 50% reduction in parasitemia compared to control (100% parasitemia).
.Morphological changes in erythrocytes
To assess morphological changes in erythrocytes attributed due to extract concentration erythrocytes were incubated with the highest concentration of the extract used in the antiplasmodial assay and maintained the same condition as in the case of antiplasmodial assay along with the control uninfected erythrocytes without extract. After 48 h of incubation, thin blood smears were stained with Giemsa stain and observed for morphological changes under microscope. The morphological findings were compared with control [16] . The preliminary phytochemical test was carried out using specific reagents through standard Procedure [17] .
1.1.6
Brine shrimp toxicity bioassay Inhibition of the growth of brine shrimps (Artemia salina ) was used as a measure of the toxicity of the extract using brine shrimp lethality bioassay [18 ] . The eggs of the brine shrimp were collected from an aquarium shop (Mumbai, India) and hatched in artificial sea water (38g/lit saline) under constant aeration for 48 h. After hatching active nauplii free from egg shells were collected from brighter portion of the hatching chamber and used for the bioassay. Extracts were dissolved in DMSO and then serially diluted in artificial sea water to the desired concentrations. The final DMSO concentration did not exceed 1%, which was shown not to have any harmful effect on the larvae. About 0.5 ml of diluted test solution was added to the pre marked test tubes containing 4.5ml of artificial sea water. Finally 10 active shrimps were added into each test tube. A vial containing 50µl DMSO diluted to 5 ml was used as control. Potassium permanganate (LC50 =5 μg /mL) was used as positive control, and vials containing shrimps, but without any extracts were included in each test. After 24 h the numbers of the survivors were counted using a magnifying glass and % mortality was calculated for each dilution as well as for control. The toxicity of each extract was determined from LC50 values (Lethal concentration of sample required to kill 50% of brine shrimp) in a set of three test tubes per dose.
III. Results
The basic measurement of antimalarial activity used in this study was the reduction in number of parasitized erythrocytes in extract treated test cultures as compared to control (100% parasitemia) without drug at 48 h of incubation period.
From the literature antimalarial activity of extracts was defined according to the IC50 values obtained. An extract showing an IC50 value ≤ 50 μg/mL was classified as active and extracts with activity beyond this range were considered in active [19] .
Based on this classification, the ethyl acetate extract of Citrus aurantifolia (Christm) induced a significant decrease of parasite proliferation and showed promising antimalarial activity (IC 50 of 42.73μg/mL), as compared to methanolic (IC 50 of 94.18 μg/mL). The aqueous extract (IC 50 >100 μg/mL) was found inactive.
The microscopic observation of the uninfected erythrocytes incubated with the highest concentration of extract used in assay and normal erythrocytes without drug from the blank column of the 96 well plates showed no morphological difference after 48 h of incubation
The preliminary phytochemical screening of aerial parts of the plant C. aurantifolia showed the presence of alkaloids, saponins, flavonoids and glycosides in all the three extract form.
A brine shrimp cytotoxicity assay was used to predict the potential toxicity of the extracts. The selectivity index (SI) is defined as the ratio of the brine shrimp toxicity to the anti-plasmodial activity and is determined by dividing the LC 50 values for the brine shrimp nauplii by the IC 50 value for Plasmodium falciparum. The extract with higher selectivity (high SI value) indicate potentially safer therapy.
In brine shrimp lethality bioassay, % mortality increased gradually with increase in concentration of the test samples in comparison to positive control KMnO 4 . The toxicity potentiality exhibited by Citrus aurantifolia was very negligible or did not show any apparent toxicity as compared to control. The results suggest that all the extract of C. aurantifolia possesses considerable antiplasmodial activity and negligible cytotoxicity with selectivity index (SI value) ranged from 3.50 to 4.01.
IV. Discussion
Crude extracts are the simplest of available medications and are still promoted by WHO policies as emerging alternative systems of medicine to reach the large population not covered by formal medical care in remote areas. Developing countries, where malaria is endemic, depend strongly on traditional medicine as a source for inexpensive treatment of this disease [3] . The present study aids important impetus to the area of new antimalarial agents from plants source. Earlier claims show that the plant is used in traditional medicine and cultivated throughout India [20] .
Different solvent extract of any particular plant held different antimalarial activity. The present study was investigated with the extract derived from aerial parts of the plant, Citrus aurantifolia (Christm). Out of the three extract form the ethyl acetate extract of this plant has shown highest antimalarial activity (IC 50 42.73 μg/mL) as compared to methanol and aqueous extracts. This revealed that the active compounds are more soluble in non polar solvent as compared to methanol and water extract, and that changes the efficacy on parasites.
The antiplasmodial activity of this plant was previously reported showed antimalarial activity at higher concentration [19] in methanol extract. In the present investigations the ethyl acetate extract of aerial parts of very young plant at fruiting stage, demonstrated promising antimalarial activity. Importantly, many cases are known where the crude biological extract is more efficient pharmacologically than the most active purified compound from this extract. This could be due to synergism with other compounds present in the extract, which as such have no pharmacological activity [21] . It is also evident that none of the three solvent extract tested was toxic to the arthropod Artemia salina (Artemiidae) nauplii. This observation may be an indicator of their safety as drugs for mammalian organism. The results are summarized in table 1.
V. Conclusion
The present study provided evidence for the rational exploration of Indian medicinal plants as a source of antiplasmodial agents. The plant extracts however possess moderate antimalarial activity when compared with standard drug chloroquine. The results are encouraging and further work is needed for complete isolation, identification, and characterization to elucidate the active compound and their in-vivo anti-malarial efficacy in murine malaria model with comprehensive animal toxicity study.
